20 January 2020

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

20 January 2020 | n=37

  1. Saito A, Sultana T, Ode H, Nohata K, et al.
    The 4th and 112th residues of viral capsid cooperatively modulate capsid-CPSF6 interactions of HIV-1.
    AIDS Res Hum Retroviruses 2020.

  2. Ciccullo A, Baldin G, Lombardi F, Borghetti A, et al.
    HIV DNA decay in a treatment-naive patient starting dolutegravir plus lamivudine with resistance mutations to integrase inhibitors: a case report.
    AIDS Res Hum Retroviruses 2020.

  3. Hernandez-Sanchez PG, Guerra-Palomares SE, Arguello JR, Noyola DE, et al.
    Diversity of Mexican HIV-1 Protease Sequences.
    AIDS Res Hum Retroviruses 2020.

  4. Law JKC, Butler LT, Hamill MM.
    Predictors of discontinuation of efavirenz as treatment for HIV, due to neuropsychiatric side effects, in a multi-ethnic sample in the UK.
    AIDS Res Hum Retroviruses 2020.

  5. Krakower DS, Daskalakis DC, Feinberg J, Marcus JL, et al.
    Tenofovir Alafenamide for HIV Preexposure Prophylaxis: What Can We DISCOVER About Its True Value?
    Ann Intern Med 2020.

  6. Huang YA, Tao G, Smith DK, Hoover KW, et al.
    Persistence with HIV Preexposure Prophylaxis in the United States, 2012-2017.
    Clin Infect Dis 2020.

  7. Hiransuthikul A, Himmad L, Kerr SJ, Janamnuaysook R, et al.
    Drug-drug interactions among Thai HIV-positive transgender women undergoing feminizing hormone therapy and antiretroviral therapy: the iFACT study.
    Clin Infect Dis 2020.

  8. Siegler AJ.
    Needed: A Life Course Perspective on Maintaining PrEP Use.
    Clin Infect Dis 2020.

  9. Sun J, Brown TT, Tong W, Samuels D, et al.
    African Mitochondrial DNA Haplogroup L2 is Associated with Slower Decline of beta-Cell Function and Lower Incidence of Diabetes Mellitus in non-Hispanic Black Women with HIV.
    Clin Infect Dis 2020.

  10. Maswabi K, Ajibola G, Bennett K, Capparelli EV, et al.
    Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life.
    Clin Infect Dis 2020.

  11. Kuhn L.
    Early Infant Treatment: Still a long way to go to reach HIV remission.
    Clin Infect Dis 2020.

  12. Turner D, Lockhart E, Wang W, Shore R, et al.
    PrEP implementation behaviors of community-based HIV testing staff: A mixed methods approach using latent class analysis.
    J Acquir Immune Defic Syndr 2020.

  13. Phillips G 2nd, Raman AB, Felt D, McCuskey DJ, et al.
    PrEP4Love: The Role of Messaging and Prevention Advocacy in PrEP Attitudes, Perceptions, and Uptake Among YMSM and Transgender Women.
    J Acquir Immune Defic Syndr 2020.

  14. Weiss KM, Prasad P, Ramaraju R, Zlotorzynska M, et al.
    Estimated Number of Men who have Sex with Men with Indications for HIV Pre-Exposure Prophylaxis in a National Sexual Network Study.
    J Acquir Immune Defic Syndr 2020.

  15. Flax VL, Kasasa S, Ssendagire S, Lane C, et al.
    Using a quality improvement approach in the prevention of mother-to-child HIV transmission program in Uganda improves key outcomes and is sustainable in demonstration facilities: Partnership for HIV-Free Survival.
    J Acquir Immune Defic Syndr 2020.

  16. Keen P, Hammoud MA, Bourne A, Bavinton BR, et al.
    Use of HIV Pre-exposure Prophylaxis (PrEP) Associated With Lower HIV Anxiety Among Gay and Bisexual Men in Australia Who Are at High Risk of HIV Infection: Results From the Flux Study.
    J Acquir Immune Defic Syndr 2020;83:119-125.

  17. .
    A Meta-analysis Assessing Diarrhea and Pneumonia in HIV-Exposed Uninfected Compared With HIV-Unexposed Uninfected Infants and Children: Erratum.
    J Acquir Immune Defic Syndr 2020;83:e13-e14.

  18. .
    Using Interrupted Time Series Analysis to Measure the Impact of Legalized Syringe Exchange on HIV Diagnoses in Baltimore and Philadelphia: Erratum.
    J Acquir Immune Defic Syndr 2020;83:e12.

  19. Lippman SA, West R, Gomez-Olive FX, Leslie HH, et al.
    Treatment as Prevention-Provider Knowledge and Counseling Lag Behind Global Campaigns.
    J Acquir Immune Defic Syndr 2020;83:e9-e12.

  20. Arya M, Marren RE, Marek HG, Pasalar S, et al.
    Success of Supplementing National HIV Testing Recommendations With a Local Initiative in a Large Health Care System in the U.S. South.
    J Acquir Immune Defic Syndr 2020;83:e6-e9.

  21. Qin S, Vodovotz L, Zamora R, Fitzpatrick M, et al.
    Association Between Inflammatory Pathways and Phenotypes of Pulmonary Dysfunction Using Cluster Analysis in Persons Living With HIV and HIV-Uninfected Individuals.
    J Acquir Immune Defic Syndr 2020;83:189-196.

  22. Wadley AL, Lazarus E, Gray GE, Mitchell D, et al.
    Pain in Clients Attending a South African Voluntary Counseling and Testing Center Was Frequent and Extensive But Did Not Depend on HIV Status.
    J Acquir Immune Defic Syndr 2020;83:181-188.

  23. Aizire J, Brooks KM, Mirochnick M, Flynn PM, et al.
    Antenatal Intracellular Concentrations of Tenofovir Diphosphate and Emtricitabine Triphosphate and Associations Between Tenofovir Diphosphate and Severe Adverse Pregnancy Outcomes: IMPAACT-PROMISE (1077BF) Trial.
    J Acquir Immune Defic Syndr 2020;83:173-180.

  24. Thomsen MT, Wiegandt YL, Gelpi M, Knudsen AD, et al.
    Prevalence of and Risk Factors for Low Bone Mineral Density Assessed by Quantitative Computed Tomography in People Living With HIV and Uninfected Controls.
    J Acquir Immune Defic Syndr 2020;83:165-172.

  25. Millham LRI, Scott JA, Sax PE, Shebl FM, et al.
    Clinical and Economic Impact of Ibalizumab for People With Multidrug-Resistant HIV in the United States.
    J Acquir Immune Defic Syndr 2020;83:148-156.

  26. Hughes E, Mwebaza N, Huang L, Kajubi R, et al.
    Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women.
    J Acquir Immune Defic Syndr 2020;83:140-147.

  27. Bunge KE, Levy L, Szydlo DW, Zhang J, et al.
    Brief Report: Phase IIa Safety Study of a Vaginal Ring Containing Dapivirine in Adolescent Young Women.
    J Acquir Immune Defic Syndr 2020;83:135-139.

  28. Biello KB, Goedel WC, Edeza A, Safren SA, et al.
    Network-Level Correlates of Sexual Risk Among Male Sex Workers in the United States: A Dyadic Analysis.
    J Acquir Immune Defic Syndr 2020;83:111-118.

  29. Chow EPF, Phillips TR, Bradshaw CS, Chen MY, et al.
    Brief Report: Sexual Mixing Patterns by HIV Status and PrEP Use Among Men Who Have Sex With Men Partnerships in Melbourne, 2011-2018.
    J Acquir Immune Defic Syndr 2020;83:99-102.

  30. Mann JK, Rajkoomar E, Jin SW, Mkhize Q, et al.
    Consequences of HLA-associated mutations in HIV-1 subtype C Nef on HLA-I down-regulation ability.
    J Med Virol 2020.

  31. Miyagi E, Welbourn S, Sukegawa S, Fabryova H, et al.
    Inhibition of Vif-mediated degradation of APOBEC3G through competitive binding of Core-binding factor beta (CBFbeta).
    J Virol 2020.

  32. Zurnic Bonisch I, Dirix L, Lemmens V, Borrenberghs D, et al.
    Capsid labelled HIV to investigate the role of capsid during nuclear import and integration.
    J Virol 2020.

  33. Stoneham CA, Ramirez PW, Singh R, Suarez M, et al.
    A conserved acidic cluster motif in SERINC5 confers partial resistance to antagonism by HIV-1 Nef.
    J Virol 2020.

  34. Yang YR, McCoy LE, van Gils MJ, Andrabi R, et al.
    Autologous neutralizing antibody responses to an HIV envelope glycan hole are not easily broadened in rabbits.
    J Virol 2020.

  35. Prevost J, Edgar CR, Richard J, Trothen SM, et al.
    HIV-1 Vpu downregulates Tim-3 from the surface of infected CD4(+) T cells.
    J Virol 2020.

  36. Wang S, Voronin Y, Zhao P, Ishihara M, et al.
    Glycan profiles of gp120 protein vaccines from four major HIV-1 subtypes produced from different host cell lines under non-GMP or GMP conditions.
    J Virol 2020.

  37. Buchholz B, Niehues T.
    Lost in Transition: A Risk Factor for Mortality in Youth Living With HIV.
    Pediatr Infect Dis J 2020;39:e14-e16.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

20 January 2020

13 January 2020

01 January 2020

21 December 2019

16 December 2019


20 January 2020

Multidisciplinary Journal Club

  1. Birnbaum J, Scharf S, Schmidt S, Jonscher E, et al.
    A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites.
    Science. 2020;367:51-59.

  2. Buron MD, Chalmer TA, Sellebjerg F, Frederiksen J, et al.
    Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study.
    Neurology. 2019;92:e1811-e1820.

  3. Bartlett NL.
    Treatment of Nodular Lymphocyte Hodgkin Lymphoma: The Goldilocks Principle.
    J Clin Oncol. 2020 Jan 10:JCO1902816. doi: 10.1200/JCO.19.02816.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016